Bob Harrington

Robert A. Harrington, MD The Bob Harrington Show

Robert A. Harrington, MD, is the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and Provost for Medical Affairs at Cornell University, New York. A former president of the American Heart Association, he cares deeply about the generation of evidence to guide clinical practice.

When not focusing on medicine, Harrington dreams of being a radio commentator for the Boston Red Sox.

The Bob Harrington Show is a podcast series of thoughtful interviews and discussions on topics at the core of cardiology and the practice of medicine.

Subscribe on Apple Podcasts, Spotify, or your preferred podcast provider.

 

Latest Articles by Bob Harrington

  • Topics Cardiologists Love to Hate: MOC and AI   Bob Harrington and Mike Gibson discuss two of the hottest topics in cardiology and medicine for 2023: a proposed alternative to the maintenance of certification process, and artificial intelligence.
  • The Top Cardiology Trials of 2023   For this year's review, Bob Harrington and Mike Gibson revisit the major cardiology conferences -- from ACC in New Orleans to AHA in Philly.
  • SCD in Athletes: Lessons From High-Profile Cases   Bob Harrington and Manesh Patel discuss sudden cardiac death in athletes, and how cases such as Bronny James' and Damar Hamlin's highlight the importance of the chain of survival.
  • From Physician to Patient to Reinventing Medicine   Bob Harrington interviews Jag Singh about the COVID journey that led to his book, "Future Care: Sensors, Artificial Intelligence, and the Reinvention of Medicine."
  • AI and Machine Learning in Healthcare for the Clueless   Robert Harrington and Jenine John, a cardiologist and machine-learning research fellow, discuss what you need to know about AI and machine learning in healthcare and where to find some helpful resources.
  • The Career Pivot: Leaving Clinical Medicine   Bob Harrington talks to two former colleagues who made a mid- and senior-career switch to pharma and digital tech, respectively. How did they make this decision and what advice do they have for others?
  • Top Cardiology Trials of 2022   Trials on heart failure, hypertension and lipid-lowering drugs, and the evolution of antithrombin and antiplatelet therapy are discussed in part 2 of cardiologists Bob Harrington and Mike Gibson's annual review.
  • 2022 in Review Through a Cardiology Lens   In part 1 of their annual review, cardiologists Bob Harrington and Mike Gibson discuss in-person meetings, wearables and AI, COVID lessons for medical research, and the growth of RCTs from China.
  • What Do We Know About Long COVID: A Cardiovascular Focus   Drs Bob Harrington and Betty Raman discuss the cardiovascular impact and long-term sequelae of COVID-19, the potential biology behind multisystem effects, and ongoing research.
  • Do Older vs Younger Docs Treat AF Differently?   Do cardiologists from the AFFIRM generation treat AF less aggressively than the EAST-AFNET generation? Bob Harrington and Jonathan Piccini discuss this and upcoming trials on atrial fibrillation.